Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?
Robert G
RG
Uzzo
D014408:Biomarkers, Tumor / Q000097:blood*; D002256:Carbonic Anhydrases / Q000097:blood; D002292:Carcinoma, Renal Cell / Q000097:blood* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003657:Decision Making; D019317:Evidence-Based Medicine; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood* / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000592:standards / Q000639:trends; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D014408:Biomarkers, Tumor; D002256:Carbonic Anhydrases